Board member Shirley Wu resigns; Rong Yang appointed as director effective June 1, 2022

NATURES SUNSHINE PRODUCTS INC

Shirley Wu resigned from the Board effective May 31, 2022, not due to any disagreement with the Company.
Rong Yang appointed to the Board effective June 1, 2022, designated by Fosun.
Yang is CEO of Fosun Pharma USA and Chief Representative of Fosun Group in the US.
Board determined Yang is independent under Nasdaq standards despite his Fosun affiliation.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Rong Yang

Director

NATR · NATURES SUNSHINE PRODUCTS INC

Effective: 2022-06-01
Filed: June 3, 2022, 7:59 PM ET

Effective June 1, 2022, the Company’s Board of Directors appointed Mr. Rong Yang to its Board of Directors.

Departed

Shirley Wu

Director

NATR · NATURES SUNSHINE PRODUCTS INC

Effective: 2022-05-31
Filed: June 3, 2022, 7:59 PM ET

Ms. Shirley Wu resigned from the Board of Directors of Nature’s Sunshine Products, Inc. (the “Company”) effective May 31, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Rong Yang was appointed as Director at NATURES SUNSHINE PRODUCTS INC.

Action: appointed
Role: Director

Exact text from the filing

Effective June 1, 2022, the Company’s Board of Directors appointed Mr. Rong Yang to its Board of Directors.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Shirley Wu resigned as Director at NATURES SUNSHINE PRODUCTS INC.

Action: resigned
Role: Director

Exact text from the filing

Ms. Shirley Wu resigned from the Board of Directors of Nature’s Sunshine Products, Inc. (the “Company”) effective May 31, 2022.

View on SEC.gov

NATURES SUNSHINE PRODUCTS INC filing history →

Source: SEC EDGAR

accession 0000275053-22-000013

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.